Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001808805-21-000026)

Filing Details

Accession Number:: 0001808805-21-000026
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2021-12-01 21:41:03
Reporting Period:: 2021-11-30

Accepted Time:: 2021-12-01 21:41:03
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1808805	Nautilus Biotechnology Inc.	NAUT	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1543792	L. Matthew Posard	C/O Nautilus Biotechnology, Inc. 2701 Eastlake Avenue East Seattle WA 98102		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2021-11-30	20,000	$4.57	20,000	No	4	P	Direct
Common Stock	Acquisiton	2021-12-01	10,000	$4.50	30,000	No	4	P	Direct
Common Stock	Acquisiton	2021-12-01	10,000	$4.46	40,000	No	4	P	Direct
Common Stock	Acquisiton	2021-12-01	10,000	$4.45	50,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	100,000	Indirect	See Footnote

Footnotes

Shares held by the Matthew and Elizabeth Posard Trust. The reporting person is the Trustee of the Matthew and Elizabeth Posard Trust.